Clobazam Tablet
Product Images NDC 69238-1306

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 69238-1306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4 (Clobazam Tablets 1)

Chemical structure of clobazam, showing its molecular arrangement with a chlorinated benzodiazepine core, including a methyl group, chlorine atom, and phenyl group attached.*

FDA Label Image

2 (Clobazam Tablets 2)

A bar chart depicting the percentage reduction in weekly drop seizure rate across four groups: Placebo, Low, Medium, and High. The chart shows increasing reductions from placebo to high, with statistical significance noted for low, medium, and high dose groups. Sample sizes for each group are 57, 53, 58, and 49 respectively.*

FDA Label Image

3 (Clobazam Tablets 3)

A bar chart showing the proportion of patients (%) by categories of reduction in weekly drop seizure frequency from baseline (%) for four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High. The x-axis displays seven reduction categories ranging from 'Worse' to '80 to 100', while the y-axis indicates the proportion of patients in percentage.*

FDA Label Image

10 (Clobazam Tablets 4)

Clobazam Tablets 10 mg oral tablets label for a 100-tablet bottle. The label shows the strength (10 mg), a small tablet image marked with 'C' and 'Z', directions for the pharmacist, and manufacturer information from Amneal Pharmaceuticals NY LLC. It includes an NDC number 69238-1305-1 and references a medication guide link and QR code.*

FDA Label Image

20 (Clobazam Tablets 5)

Label for Clobazam Tablets 20 mg, oral tablets manufactured by Amneal Pharmaceuticals NY LLC. The label includes the NDC number 69238-1306-1 and indicates the package contains 100 tablets. Instructions for pharmacists include dispensing the medication guide to each patient. Storage instructions specify 20 to 25°C (68 to 77°F), and the label notes the tablets are controlled room temperature stable and dispensed in a USP tight container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.